Search research articles
Contact Us
Filters
Showing results (121-130 of 146) with videos related to
Page
of 15
Sort By:
BMC Medical Genomics
|
March 8, 2018
Whole exome sequencing in three families segregating a pediatric case of sarcoidosis
Alain Calender, Pierre Antoine Rollat Farnier, Adrien Buisson, et al.
American Journal of Human Genetics
|
June 16, 2015
RSPH3 Mutations Cause Primary Ciliary Dyskinesia with Central-Complex Defects and a Near Absence of Radial Spokes
Ludovic Jeanson, Bruno Copin, Jean-François Papon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 28, 2020
Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function
Pierre-Régis Burgel, Isabelle Durieu, Raphaël Chiron, et al.
Human Molecular Genetics
|
February 8, 2017
Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics
Lisa J Strug, Tanja Gonska, Gengming He, et al.
The Lancet. Respiratory Medicine
|
October 25, 2025
Effect of elexacaftor-tezacaftor-ivacaftor on bronchial dilatations in adolescents with cystic fibrosis: a multicentre prospective observational study
Isabelle Sermet-Gaudelus, Alexia Letierce, Laureline Berteloot, et al.
Orphanet Journal of Rare Diseases
|
April 22, 2018
Pulmonary hemosiderosis in children with Down syndrome: a national experience
Aurelia Alimi, Jessica Taytard, Rola Abou Taam, et al.
Plos Genetics
|
February 27, 2019
Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci
Jiafen Gong, Fan Wang, Bowei Xiao, et al.
HGG Advances
|
February 7, 2022
Leveraging TOPMed imputation server and constructing a cohort-specific imputation reference panel to enhance genotype imputation among cystic fibrosis patients
Quan Sun, Weifang Liu, Jonathan D Rosen, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 31, 2017
Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity
Deepika Polineni, Hong Dang, Paul J Gallins, et al.
Clinical and Translational Science
|
May 10, 2025
Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic Fibrosis
Ngoc Hoa Truong, Sihem Benaboud, Naïm Bouazza, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 146) with videos related to
Sort By:
Page
of 15
BMC Medical Genomics
|
March 8, 2018
Whole exome sequencing in three families segregating a pediatric case of sarcoidosis
Alain Calender, Pierre Antoine Rollat Farnier, Adrien Buisson, et al.
American Journal of Human Genetics
|
June 16, 2015
RSPH3 Mutations Cause Primary Ciliary Dyskinesia with Central-Complex Defects and a Near Absence of Radial Spokes
Ludovic Jeanson, Bruno Copin, Jean-François Papon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 28, 2020
Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function
Pierre-Régis Burgel, Isabelle Durieu, Raphaël Chiron, et al.
Human Molecular Genetics
|
February 8, 2017
Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics
Lisa J Strug, Tanja Gonska, Gengming He, et al.
The Lancet. Respiratory Medicine
|
October 25, 2025
Effect of elexacaftor-tezacaftor-ivacaftor on bronchial dilatations in adolescents with cystic fibrosis: a multicentre prospective observational study
Isabelle Sermet-Gaudelus, Alexia Letierce, Laureline Berteloot, et al.
Orphanet Journal of Rare Diseases
|
April 22, 2018
Pulmonary hemosiderosis in children with Down syndrome: a national experience
Aurelia Alimi, Jessica Taytard, Rola Abou Taam, et al.
Plos Genetics
|
February 27, 2019
Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci
Jiafen Gong, Fan Wang, Bowei Xiao, et al.
HGG Advances
|
February 7, 2022
Leveraging TOPMed imputation server and constructing a cohort-specific imputation reference panel to enhance genotype imputation among cystic fibrosis patients
Quan Sun, Weifang Liu, Jonathan D Rosen, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 31, 2017
Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity
Deepika Polineni, Hong Dang, Paul J Gallins, et al.
Clinical and Translational Science
|
May 10, 2025
Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic Fibrosis
Ngoc Hoa Truong, Sihem Benaboud, Naïm Bouazza, et al.
Page
of 15